Original Research
Published on 10 May 2024
Vandetanib as a prospective anti-inflammatory and anti-contractile agent in asthma
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1345070
- 2,762 views
14 articles related to "Vandetanib"
Articles
Original Research
Published on 03 Mar 2025
Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1526159
- 2,578 views
- 1 citation
Original Research
Published on 29 Sep 2021
Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma – Lessons From Individual Cases With Long-Term Follow-Up
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.718418
- 4,260 views
- 7 citations
Systematic Review
Published on 03 May 2018
Efficacy of Vandetanib in Treating Locally Advanced or Metastatic Medullary Thyroid Carcinoma According to RECIST Criteria: A Systematic Review and Meta-Analysis
in Thyroid Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2018.00224
- 8,446 views
- 31 citations
Original Research
Published on 18 Dec 2018
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration
in Thyroid Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2018.00764
- 4,557 views
- 26 citations
PDF-read only
Review
Published on 10 Jul 2018
Clinical development of RET inhibitors in RET-rearranged non-small cell lung cancer: Update
Oncology Reviews
doi 10.4081/oncol.2018.352
Review
Published on 28 May 2021
Angiogenesis Inhibitors in Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.655316
- 12,156 views
- 62 citations
Review
Published on 06 Oct 2017
Targeted Therapy for Medullary Thyroid Cancer: A Review
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2017.00238
- 23,694 views
- 51 citations
Original Research
Published on 29 Jun 2022
A Computational Framework to Characterize the Cancer Drug Induced Effect on Aging Using Transcriptomic Data
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.906429
- 3,415 views
- 4 citations
Case Report
Published on 07 Aug 2020
A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2020.00490
- 6,327 views
- 23 citations
Review
Published on 19 Nov 2021
Tyrosine Kinase Inhibitors-Induced Arrhythmias: From Molecular Mechanisms, Pharmacokinetics to Therapeutic Strategies
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2021.758010
- 8,687 views
- 27 citations
Review
Published on 20 Nov 2015
Molecular Targeted Therapies of Aggressive Thyroid Cancer
in Thyroid Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2015.00176
- 11,876 views
- 61 citations
Original Research
Published on 10 Jul 2023
Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1229960
- 6,233 views
- 14 citations
Systematic Review
Published on 26 Aug 2022
Efficacy and safety of targeted therapeutics for patients with radioiodine-refractory differentiated thyroid cancer: Systematic review and network meta-analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2022.933648
- 7,878 views
- 12 citations